Navigation Links
Putney, Inc. Enters the $175M Annual Veterinary NSAID Market
Date:6/23/2009

Makes Treatment More Affordable to Pet Owners

PORTLAND, Maine, June 23 /PRNewswire/ -- Putney, Inc., a pharmaceutical company focused on the development of generic drugs for pets, has launched carprofen caplets, a bioequivalent generic version of the canine medication Rimadyl(R) caplets. Putney's carprofen is offered so as to cost at least 25% less to veterinarians than its branded competitor -- allowing veterinarians to provide savings for pet owners and increasing profits to veterinary practices in this tough economy.

Carprofen is widely used in dogs for the relief of pain and inflammation associated with osteoarthritis, as well as the control of post-operative pain associated with soft tissue and orthopedic surgeries. In a recent survey conducted by Advanstar Veterinary Healthcare Communications, 96% of responding veterinarians nationwide indicated they prescribe and dispense branded carprofen medications. Putney's carprofen caplets have demonstrated bioequivalence to Pfizer's Rimadyl(R) caplets in an FDA approved study and will be available in the same strengths (25mg, 75mg and 100mg caplets) and convenient packaging as the branded drug.

In the Advanstar survey, 80% of companion animal veterinarians surveyed across the country responded that they would feel comfortable switching to generic carprofen caplets and 88% believe that pet owners are receptive to switching to the generic.

In general, in spite of expired patents on many veterinary drugs, few cost-saving generics have been developed and approved by the FDA for pets. "With carprofen caplets, Putney is delivering a high quality, bioequivalent generic option to veterinarians to help pet owners afford to treat pets," said Jean Hoffman, CEO and founder of Putney. Carprofen caplets are the first FDA approved veterinary generic in Putney's pipeline of veterinary generic and specialty drugs. Ms. Hoffman says Putney expects future sales of more than $20 million annually for carprofen products, subject to FDA approval for the Company's generic drug applications for various forms of carprofen. Putney's carprofen caplets are available from selected licensed veterinary distributors such as First Veterinary Supply in Michigan -- and directly from Putney for large veterinary practices.

Putney, Inc., is a pharmaceutical company that listens to companion animal veterinarians and responds to their needs -- making affordable drugs available, and developing products that address common concerns such as compliance, dosing and palatability. Putney empowers veterinarians with prescribing choices that allow them to pursue the best course of treatment for improved compliance, more satisfied pet owners and happy pets. Learn more at www.putneyvet.com.

Available Topic Expert(s): For information on the listed expert(s), click appropriate link.

https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=88021


'/>"/>
SOURCE Putney, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Sagent Pharmaceuticals Enters Into a $15 Million Revolving Credit Facility
2. Joint Commission President Emeritus Joins Truman Medical Centers Board of Directors
3. VIDEO: Cancer Treatment Centers of America Selects Site in GA for Proposed Hospital Serving Patients in Southeast
4. U-M Hospitals & Health Centers Weathers Tough Economic Climate, Plans for Growth
5. Leading Healthcare Group Selects Varian Medical Systems to Supply Cancer Treatment Technology for Treatment Centers Across the Western United States
6. Help for Struggling CPAP Users Comes to Sleep HealthCenters in Weymouth
7. AGH Joins Select Group of Medical Centers in Study of Promising New Technology for Treatment of Heart Failure
8. VIDEO from Medialink and the Defense Centers of Excellence for Psychological Health and Traumatic Brain Injury: Department of Defense Launches New Anti-Stigma Campaign
9. Ambulatory Surgery Centers Pivotal in Moving Outpatient Surgical Services Into Less Expensive, Clinically Appropriate Settings
10. SETO Holdings, Inc. Completes Agreement to Acquire Advanced Hearing Centers, Inc. and Has Disposed of All Existing Business; New Management has been installed
11. Forterus Inc. Treatment Centers Serving Middle-Class; Rapid Growth Detailed in Paul Howarth Interview
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/2/2016)... ... , ... Further establishing itself as a leader in natural pet products category, ... were selected from over 1,000 entrants as a winner and recipient of the prestigious ... for dogs are a favorite product among pet-parents worldwide, as each whimsical knobby shape ...
(Date:5/2/2016)... ... May 02, 2016 , ... Zitter Health Insights ... Patient Satisfaction Award that will recognize specialty pharmacies for their achievements in customer ... Insights’ Specialty Pharmacy Patient Satisfaction Survey compiled throughout 2016. Results will be published ...
(Date:5/2/2016)... ... May 02, 2016 , ... Dr. Rassouli, dentist in Orange ... decline. According to the research, which was published in the “Journal of the American ... and about 5.4 million Americans have Alzheimer’s disease. The study found that dental problems ...
(Date:5/2/2016)... ... May 02, 2016 , ... Visceral fat, also known ... the kidneys, liver and pancreas. If not properly addressed, visceral fat can lead ... Internal Medicine, Medical Oncology and Palliative Care, warns against the dangers of visceral ...
(Date:5/2/2016)... (PRWEB) , ... May 02, 2016 , ... The 2016 World Ultimate & Guts Championship ... Camp at Manhattan College, made the cut. The WUGC is being held in London, England ... won the gold in the men’s division, another gold in the women’s masters division, and ...
Breaking Medicine News(10 mins):
(Date:5/2/2016)... , May 2, 2016  Deerfield announced ... financing of Graybug Vision, Inc. Graybug Vision is ... therapies that may transform care for ocular diseases ... Graybug Vision,s technology was first developed at Johns ... a startup venture. Graybug Vision ...
(Date:5/2/2016)...  While nearly three-quarters of Americans (71%) are aware ... health, only about half report taking any steps to ... a new survey announced today by Hologic (Nasdaq: ... Osteoporosis Month, Hologic is raising awareness of this major ... Americans. Osteoporosis is a disease that causes ...
(Date:5/2/2016)... May 2, 2016  Celsion Corporation (NASDAQ: ... announced data from the first cohort of patients ... (the OVATION Study) combining GEN-1, the Company,s DNA-based ... treatment of newly-diagnosed patients with advanced ovarian cancer ... debulking surgery.  In the first three patients dosed, ...
Breaking Medicine Technology: